To prevent AVB, the 2020 American College of Rheumatology Guidelines for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases recommends hydroxychloroquine during pregnancy for all women with anti-SSA/Ro and/or anti-SSB/La antibodies (10). This evidence concerns the gene CALR and musculoskeletal system disorder.